I initiated a position in GSK recently. The stock is attractively priced, partly due to currency effects, and the weak pound will continue to be a tailwind for the business. The company returned to growth, but it needs to gain more momentum. …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
Dear Mr. Berko: My broker has recommended that I invest $20,000 and buy 500 shares of GlaxoSmithKline, a world-class drug company. The dividend is $2.48 and that yields a very attractive 5.9 percent He thinks Glaxo's problems are …
We were so impressed that we also bought 200 shares of GlaxoSmithKline, which makes this inhaler. We paid $54 for each share in the summer of 2014. The stock seemed to fall in value right after we bought it, and it fell all the way to …
Under the agreement, Valneva will conduct an R&D program on behalf of GSK to develop and improve upstream processes ... Valneva is incorporated in Lyon, France, listed on Euronext-Paris and the Vienna stock exchange and has …
Emma Walmsley, who has described herself as "extremely ... remuneration from shareholders had also played a role, it said. GSK is the fifth largest company traded on the London Stock Exchange and as head of its Consumer Healthcare …
BBC1y
An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late stage trial, according to data …
GlaxoSmithKline Consumer Healthcare has consolidated its global agency roster to nine shops across advertising, digital, content, PR, expert marketing and shopper marketing to support its leading brands, such as Sensodyne and …